Oxitriptan

Add links
Source: Wikipedia, the free encyclopedia.
This article is about 5-HTP (oxitriptan) as a medication and supplement. For its role as a biological compound, see
5-hydroxytryptophan
.

Oxitriptan
Clinical data
Trade namesCincofarm, Levothym, Levotonine, Oxyfan, Serovit, Telesol, Trimag, Tript-OH, Triptum[1]
Other namesOxytryptan; 5-Hydroxytryptophan; L-5-Hydroxytryptophan; 5-Hydroxy-L-tryptophan; L-5-HTP; 5-HTP; α-Carboxy-5-hydroxytryptamine; α-Carboxy-5-HT
Routes of
administration		Oral[1]
Drug classSerotonin precursor; Serotonin receptor agonist
ATC code
Pharmacokinetic data
Bioavailability49 ± 19%[1]
With carbidopa: up to 84%[1]
MetabolismDecarboxylation
Metabolites• Serotonin
Elimination half-lifeOral: 4.4–7 hours[1]
IV: 2.2–7.4 hours[1]
Identifiers
  • (2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid
JSmol)
SMILES
  • C1=CC2=C(C=C1O)C(=CN2)C[C@@H](C(=O)O)N
  • InChI=1S/C11H12N2O3/c12-9(11(15)16)3-6-5-13-10-2-1-7(14)4-8(6)10/h1-2,4-5,9,13-14H,3,12H2,(H,15,16)/t9-/m0/s1
  • Key:LDCYZAJDBXYCGN-VIFPVBQESA-N

Oxitriptan, also known as L-5-hydroxytryptophan (5-HTP) and sold under various brand names, is a medication and over-the-counter dietary supplement used in the treatment of depression and for other indications.[2][1][3][4] It is taken by mouth.[1]

Side effects of oxitriptan include

appetite loss, nausea, diarrhea, vomiting, and serotonin syndrome.[1][2][3] The drug is a centrally permeable monoamine precursor and prodrug of serotonin and hence acts as a serotonin receptor agonist.[2] Chemically, oxitriptan is an amino acid and a tryptamine.[5]

Oxitriptan has been used clinically since at least the 1970s.[1]

Uses

Medical

5-HTP is sold

sleep aid. It is also marketed in many European countries for the indication of major depressive disorder under the trade names Cincofarm, Levothym, Levotonine, Oxyfan, Telesol, Tript-OH, and Triptum.[6]

A 2002 review concluded that although the data evaluated suggests that 5-HTP is more effective than placebo in the treatment of depression, the evidence was insufficient to be conclusive due to a lack of clinical data meeting the rigorous standards of the day.[7] More and larger studies using current methodologies are needed to determine if 5-HTP is truly effective in treating depression.[8][9] In small, controlled trials, 5-HTP has also been reported to augment the antidepressant efficacy of the antidepressant clomipramine.[10][11][12] A 2020 meta-analysis found oral 5-HTP supplementation had a large effect size on depression symptom severity. However, the included studies were considered relatively weak and the methods and treatment duration varied between the seven studies examined.[13]

Other uses

At high doses, or in combination with carbidopa, 5-HTP has been used to treat obesity (by promoting weight loss).[14][15]

Use after MDMA

recreational
, though sometimes also therapeutic, purposes. Among users of MDMA, the serotonergic effects of the drug are often of particular interest and concern: After consuming MDMA, serotonin concentrations are greatly reduced in the brain. 5-HTP is necessary for serotonin production and its concentrations in the brain also decrease after taking MDMA.

Side effects

Potential side effects of 5-HTP include

nightmares, and muscle problems.[16][2] Serotonin syndrome can occur.[2][3]

Because 5-HTP has not been thoroughly studied in a clinical setting, possible side effects and interactions with other drugs are not well known. According to the US National Library of Medicine, 5-HTP has not been associated with serotonin syndrome or any serious adverse events in humans.[17] Across multiple studies, 5-HTP has also been reported to not cause any noticeable hematological or cardiovascular changes.[18] 5-HTP had also been associated with eosinophilia, but later studies have not found any causal connection.[19]

Interactions

When combined with

SSRI class, very high parenteral doses of 5-HTP can cause acute serotonin syndrome in rats.[20][21] It is unclear if such findings have clinical relevance, as most drugs will cause serious adverse events or death in rodents at very high doses. In humans, 5-HTP has never been clinically associated with serotonin syndrome – although a case report suggests 5-HTP can precipitate mania when added to an MAOI.[22]

When combined with carbidopa (as a treatment for symptoms of Parkinson's disease), 5-HTP causes nausea and vomiting; however, this can be alleviated via administration of granisetron.[23] Cases of scleroderma-like illness have been reported in patients using carbidopa and 5-HTP.[24]

Oral 5-HTP results in an increase in urinary

5-HIAA, a serotonin metabolite, indicating that 5-HTP is peripherally metabolized to serotonin, which is then metabolized. This might cause false positive results in tests looking for carcinoid syndrome.[25][26] Due to the conversion of 5-HTP into serotonin by the liver, there could be a risk of heart valve disease from serotonin's effect on the heart, as based on preclinical findings.[27][28] However, 5-HTP has not been associated with cardiac toxicity in humans.[19][18][17][29]

It has been suggested that 5-HTP may cause

eosinophilia-myalgia syndrome (EMS), a serious condition which results in extreme muscle tenderness, myalgia, and blood abnormalities. However, there is evidence to show that EMS was likely caused by a contaminant in certain 5-HTP supplements.[30]

Pharmacology

The psychoactive action of 5-HTP is derived from its increase in production of serotonin in central nervous system tissue.[31]

Metabolic pathway from tryptophan to serotonin.
Metabolic pathway from tryptophan to serotonin.

Research shows that co-administration with carbidopa greatly increases plasma 5-HTP levels.[32] Other studies have indicated the risk of a scleroderma-like condition resulting from the combination of 5-HTP and carbidopa.[33]

After oral administration, 5-HTP is absorbed by the upper intestine.[34] The mode of absorption is not known, but presumably involves active transport via amino acid transporters. 5-HTP is adequately absorbed via oral cavity.[35] With a decarboxylase inhibitor, the bioavailability of 5-HTP can be higher than 50%.[36]

5-HTP is rapidly absorbed with a tmax of ≈1.5 h, and rapidly eliminated with a half-life of ≈1.5 – 2 h. Co-administration of a decarboxylase inhibitor (e.g., carbidopa, benserazide) doubles the half-life of 5-HTP to ≈ 3 – 4 h,[37][34] and enhances exposure several-fold, depending on the dosing regimen.[34][38]

5-HTP's short half-life (<2 hours)[34] may inherently limit its therapeutic potential,[39] as systemic 5-HTP exposure levels will fluctuate substantially even with relatively frequent dosing. Such exposure fluctuations are usually associated with increased adverse event burdens resulting from Cmax (time to maximal systemic concentration) drug spikes, and decreased clinical efficacy resulting from sub-therapeutic exposure for large parts of the day, when taken as a single dose unit or at intervals significantly larger than Cmax. It has been proposed that 5-HTP dosage forms achieving prolonged delivery would be more effective,[39] as has been demonstrated many times with other pharmaceuticals with short durations of action.[40] For example, controlled-release oxycodone (OxyContin) or morphine (MS-Contin) are intended to, via novel delivery mechanisms, permit pain relief for up to twelve hours with an active ingredient which only provides relief for 3 to 6 hours. However, the inherent variability amongst different people with respect to drug metabolism makes this task challenging.

Society and culture

Names

Oxitriptan is the

INNTooltip International Nonproprietary Name.[41][42][43] Brand names of oxitriptan include Cincofarm, Levothym, Levotonine, Oxyfan, Telesol, Tript-OH, and Triptum.[4][42]

Regulatory status

There are currently no approved drug products containing 5-HTP approved by the

nutraceuticals and are as such not regulated or verified for purity, integrity, or clinical efficacy or safety, mandating caution regarding human consumption.[45]

As of 25 August 2020, Hungary added 5-HTP to the controlled psychoactive substances list, prohibiting production, sale, import, storage and use, becoming the first country to do so.[46]

Natural sources

The seeds of the Griffonia simplicifolia, a climbing shrub native to West Africa and Central Africa, are used as an herbal supplement for their 5-HTP content.[47][48][49] In one 2010 trial, Griffonia simplicifolia extract appeared to increase satiety in overweight women.[50]

Research

In clinical trials of various design, 5-HTP has also been reported to treat fibromyalgia,[51] myoclonus,[52] migraine,[53] and cerebellar ataxia.[54] However, these clinical findings, as for all therapeutic findings with 5-HTP, are preliminary and need confirmation in larger trials.

Oxitriptan/carbidopa combination

A combination of oxitriptan and

oxitriptan/carbidopa
, is being developed for the potential treatment of depression.

Slow-release formulation

5-HTP's short half-life is impractical for chronic drug therapy. Research conducted at Duke University in mice has demonstrated that 5-HTP when administered as slow-release appears to gain drug properties.[55] Slow-release delivery attenuates or abolishes the peaks and valleys in 5-HTP exposure during treatment.[56] Slow-release delivery of 5-HTP markedly improved the safety profile of 5-HTP and conferred stable plasma exposure of 5-HTP and strong and sustained enhancement of brain serotonin function.[55] This discovery indicates that 5-HTP slow-release medications represent a new avenue for treatment of brain disorders responsive to serotonergic enhancement.

See also

References

  1. ^
    ISBN 978-1-58829-014-4.{{cite book}}: CS1 maint: DOI inactive as of November 2024 (link
    )
  2. ^
    PMID 33375373
    .
  3. ^
    PMID 16023217
    .
  4. ^ a b "Oxitriptan: Uses, Interactions, Mechanism of Action". DrugBank Online. 13 June 2005. Retrieved 30 September 2024.
  5. ^ "Oxitriptan". PubChem. Retrieved 30 September 2024.
  6. ISBN 978-3-88763-075-1
    .
  7. PMID 11869656
    .
  8. ^ "5-Hydroxytryptophan (5-HTP)". University of Maryland Medical Center. Archived from the original on 25 June 2017. Retrieved 9 January 2012.
  9. PMID 20579741
    .
  10. PMID 6753514
    .
  11. S2CID 11048888
    .
  12. PMID 6381336
    .
  13. PMID 31504850
    .
  14. PMID 27713360
    .
  15. PMID 28652791
    .
  16. ^ "5-HTP". U.S. National Library of Medicine. Retrieved 7 June 2015.
  17. ^ a b "5-Hydroxytryptophan, C11H12N2O3, CID 144 - PubChem".
  18. ^
    PMID 3298325
    .
  19. ^
    PMID 15068828
    .
  20. PMID 18499101
    .
  21. PMID 16488409
    .
  22. PMID 21963353
    .
  23. S2CID 23562225
    .
  24. ^ "Carbidopa/Levodopa". Truestarhealth.com. Archived from the original on 8 January 2014. Retrieved 2014-01-09.
  25. PMID 18209781
    .
  26. S2CID 207193834
    .
  27. S2CID 3035838
    .
  28. PMID 12466135
    .
  29. S2CID 2563606
    .
  30. PMID 7699627
    .
  31. ^ "5-HTP: Uses, Side Effects, Interactions and Warnings - WebMD". Archived from the original on 16 November 2009. Retrieved 2009-10-05.
  32. PMID 6175178
    .
  33. PMID 6997735
    .
  34. ^
    S2CID 37414452
    .
  35. S2CID 10651414.{{cite journal}}: CS1 maint: DOI inactive as of December 2024 (link
    )
  36. PMID 6966118
    .
  37. PMID 309271
    .
  38. S2CID 45003287
    .
  39. ^
    PMID 27692695
    .
  40. PMID 16182208
    .
  41. ISBN 978-1-4757-2085-3
    . Retrieved 30 September 2024.
  42. ^
    ISBN 978-3-88763-075-1
    .
  43. ISBN 978-94-011-4439-1
    . Retrieved 30 September 2024.
  44. ^ "Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations". Archived from the original on January 3, 2018.
  45. ^ "5-HTP: MedlinePlus Supplements". MedlinePlus. U.S. National Library of Medicine.
  46. ^ MAGYARORSZÁG HIVATALOS LAPJA. Retrieved 2021-04-28.
  47. ^ "5-Hydroxytryptophan (5-HTP)". A.D.A.M., Inc. University of Maryland Medical Center. Animated Dissection of Anatomy for Medicine, Inc. (A.D.A.M., Inc.) provided health and benefits information and technology to healthcare organizations, employers, consumers, and educational institutions
  48. PMID 21178946
    .
  49. ^ "5-hydroxy-L-tryptophan", National Center for Biotechnology Information, PubChem Compound Database, September 2004CID=439280
  50. S2CID 10651414.{{cite journal}}: CS1 maint: DOI inactive as of December 2024 (link
    )
  51. S2CID 27586915
    .
  52. S2CID 11647568
    .
  53. S2CID 2424064
    .
  54. PMID 3190503
    .
  55. ^
    PMID 26932820
    .
  56. PMID 16182208
    .


Retrieved from "https://en.wikipedia.org/w/index.php?title=Oxitriptan&oldid=1292968048"